Kanada - angličtina - Health Canada

sterimax inc - meropenem (meropenem trihydrate) - powder for solution - 500mg - meropenem (meropenem trihydrate) 500mg - carbapenems

Kanada - angličtina - Health Canada

sterimax inc - meropenem (meropenem trihydrate) - powder for solution - 1g - meropenem (meropenem trihydrate) 1g - carbapenems

Kanada - angličtina - Health Canada

auro pharma inc - meropenem (meropenem trihydrate) - powder for solution - 500mg - meropenem (meropenem trihydrate) 500mg - carbapenems

Kanada - angličtina - Health Canada

auro pharma inc - meropenem (meropenem trihydrate) - powder for solution - 1g - meropenem (meropenem trihydrate) 1g - carbapenems

Kanada - angličtina - Health Canada

sandoz canada incorporated - meropenem (meropenem trihydrate) - powder for solution - 500mg - meropenem (meropenem trihydrate) 500mg - carbapenems

Kanada - angličtina - Health Canada

sandoz canada incorporated - meropenem (meropenem trihydrate) - powder for solution - 1g - meropenem (meropenem trihydrate) 1g - carbapenems

Kanada - angličtina - Health Canada

sandoz canada incorporated - meropenem (meropenem trihydrate) - powder for solution - 500mg - meropenem (meropenem trihydrate) 500mg - carbapenems

Kanada - angličtina - Health Canada

sandoz canada incorporated - meropenem (meropenem trihydrate) - powder for solution - 1g - meropenem (meropenem trihydrate) 1g - carbapenems

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - meropenem trihydrate, quantity: 1141 mg (equivalent: meropenem, qty 1000 mg) - injection, powder for - excipient ingredients: sodium carbonate - meropenem is indicated for treatment of the following infections, in adults and children (aged 3 months and over), when the causative organisms are known or suspected to be resistant to commonly used antibiotics: community acquired lower respiratory tract infection; hospital acquired lower respiratory tract infection; complicated urinary tract infection; febrile neutropenia; intra-abdominal and gynaecological (poly microbial) infections; complicated skin and skin structure infections; meningitis; septicaemia

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - meropenem trihydrate, quantity: 1141 mg (equivalent: meropenem, qty 1000 mg) - injection, powder for - excipient ingredients: sodium carbonate - meropenem is indicated for treatment of the following infections, in adults and children (aged 3 months and over), when the causative organisms are known or suspected to be resistant to commonly used antibiotics: community acquired lower respiratory tract infection; hospital acquired lower respiratory tract infection; complicated urinary tract infection; febrile neutropenia; intra-abdominal and gynaecological (poly microbial) infections; complicated skin and skin structure infections; meningitis; septicaemia